Company intelligence / Profile preview

Quatre Lab

San Sebastián (Donostia), Gipuzkoa, Spain

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Quatre Lab is not a therapeutic developer but a commercial Contract Research Organization providing GMP‑compliant analytical and quality control services for Advanced Therapy Medicinal Products (ATMPs) from preclinical stages through commercialization, including potency, purity, strength, safety, and cell banking assays for gene and cell therapies and other advanced therapies.[1][2][4]

Modalities: Gene therapyCell therapyVaccineBiologic
Industry: Contract Research Organization

Partnerships

Elpida Therapeutics (Elpida Tx) – partnership for potency verification and quality control of advanced therapies, supporting Elpida’s rare‑disease programs including a Phase III program for SPG50 gene therapy products[1].

Beyond the preview

Go deeper on Quatre Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quatre Lab.

Explore the full profile